secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adagio Medical Holdings, Inc. (ADGM)
CIK:        0002006986
Form:       8-K
Filed at:   2024-08-19T23:59:59+00:00
Accession:  0001104659-24-090842
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adagio Medical obtains CE Mark for VT catheter, closes business combination with $35M pro forma cash
--------------------------------------------------------------------------------

- CE Mark approval and commercial launch of vCLAS catheter for ventricular tachycardia in select European markets.
- FDA approved FULCRUM-VT pivotal IDE study for VT cryoablation system; patient enrollment starts September 2024.
- Closed business combination with ARYA Sciences Acquisition Corp; shares listed on Nasdaq under ADGM on Aug 1, 2024.
- Raised approx. $84.2M from trust, PIPE, and convertible financing; pro forma cash ~$35M after transaction costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006986/000110465924090842/0001104659-24-090842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006986/000110465924090842/tm2422065d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-090842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer